Alnylam Competitors and Similar CompaniesClear all
Sorrento Therapeutics's competitors and similar companies include CureVac.
 Sorrento Therapeutics Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
| ||
Founding Date | Founding Date 2006 | Founding Date 2000 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Diego, US HQ San Diego, US | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US |
Employees | Employees 31019% decrease | Employees 999 |
Valuation ($) | Valuation ($) 1.5 m | Valuation ($) 648.3 m |
Financial | ||
Revenue (est.) | Revenue (est.) $62.8m (FY, 2022) | Revenue (est.) €53.8m (FY, 2023) |
Net income | Net income ($577.8m) (FY, 2022) | Net income (€260.2m) (FY, 2023) |
Funding | ||
Total funding raised | Total funding raised $ 42.6m | Total funding raised $ 1.1b |
For sources of this data, please see the company profile
View Company Profiles
CureVac
HQ
Tübingen, DE
Employees
999
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View company